Tags

Type your tag names separated by a space and hit enter

The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin.
Am J Gastroenterol 2008; 103(4):964-5AJ

Abstract

The findings of the lactulose breath test in irritable bowel syndrome patients have been used to suggest that most patients have small intestinal bacterial overgrowth (SIBO), and this association has spawned the widespread use of antibiotics in IBS. The study by Bratten and colleagues demonstrates that this test does not discriminate between IBS patients and healthy controls when criteria from recent clinical IBS studies are applied. When the findings from this large study are combined with previous smaller studies, they challenge the hypothesis that SIBO underlies the symptoms of IBS and undermine the current rationale for the use of antibiotics in IBS.

Authors

No affiliation info available

Pub Type(s)

Comment
Editorial

Language

eng

PubMed ID

18371132

Citation

Vanner, Stephen. "The Lactulose Breath Test for Diagnosing SIBO in IBS Patients: Another Nail in the Coffin." The American Journal of Gastroenterology, vol. 103, no. 4, 2008, pp. 964-5.
Vanner S. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol. 2008;103(4):964-5.
Vanner, S. (2008). The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. The American Journal of Gastroenterology, 103(4), pp. 964-5. doi:10.1111/j.1572-0241.2008.01798.x.
Vanner S. The Lactulose Breath Test for Diagnosing SIBO in IBS Patients: Another Nail in the Coffin. Am J Gastroenterol. 2008;103(4):964-5. PubMed PMID: 18371132.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. A1 - Vanner,Stephen, Y1 - 2008/03/26/ PY - 2008/3/29/pubmed PY - 2008/6/5/medline PY - 2008/3/29/entrez SP - 964 EP - 5 JF - The American journal of gastroenterology JO - Am. J. Gastroenterol. VL - 103 IS - 4 N2 - The findings of the lactulose breath test in irritable bowel syndrome patients have been used to suggest that most patients have small intestinal bacterial overgrowth (SIBO), and this association has spawned the widespread use of antibiotics in IBS. The study by Bratten and colleagues demonstrates that this test does not discriminate between IBS patients and healthy controls when criteria from recent clinical IBS studies are applied. When the findings from this large study are combined with previous smaller studies, they challenge the hypothesis that SIBO underlies the symptoms of IBS and undermine the current rationale for the use of antibiotics in IBS. SN - 1572-0241 UR - https://www.unboundmedicine.com/medline/citation/18371132/The_lactulose_breath_test_for_diagnosing_SIBO_in_IBS_patients:_another_nail_in_the_coffin_ L2 - http://Insights.ovid.com/pubmed?pmid=18371132 DB - PRIME DP - Unbound Medicine ER -